Ingelise Saunders

Board member

Independent board member since 2004

Nationality: Danish

Age: 62

Ingelise Saunders is CEO of SLS Invest AB and President and CEO of TD Vaccines A/S and ActionPharma A/S.

She is a member of the board of AdvanDx A/S and has previously been on the boards of Ecron Acunova A/S, Alk-Abelló A/S, Celltech Group Plc, CB Nordic ApS, Evolva Holding SA, Scandinavian Life Science Venture AB, Nordic Vaccine A/S (Chairman), and Alfalyse ApS.

Formerly, she was CEO of ACE BioSciences A/S and Celltech Pharmaceuticals Ltd.

Prior to this, Mrs Saunders held a number of executive management positions during her 15 years of employment with Novo Nordisk.

Mrs Saunders has extensive executive management experience, experience in international operations, in sales, marketing, and global commercial operations, M&A transactions and business development, healthcare strategy, and life science investments.

Mrs Saunders holds a degree in Pharmacy from the Royal Danish School of Pharmacy and a Bachelor of Commerce degree in marketing.